Using the pulse to detect peripheral artery disease in the legs
Tests a pulse timing device for finding leg artery disease in adults.
Key facts
- Who runs it
- University of Nebraska
- Where
- Omaha, United StatesSee the site
- Trial code
- Registry title
- Detecting Peripheral Artery Disease With the Pulse
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 5 Feb 2026
- Expected to end
- 1 Jan 2028
- Type of study
- Interventional
- Treatments tested
- Segmental pulse arrival time assessment
- Record updated
- 17 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 19 or older, with or without peripheral artery disease (narrowed leg arteries), to test a new way of measuring the pulse.
- Age
- 19 years or older
- Sex
- All sexes
- Disease stage
- People with or without a diagnosis of peripheral artery disease can join.
- Earlier treatment
- People who had surgery or a catheter procedure to restore blood flow in the legs or aorta cannot join.
Main reasons for not taking part
- A current or past aortic aneurysm (a bulge in the body's main artery), treated or not
- Past surgery or catheter procedure to restore blood flow in the legs or aorta
- Walking problems not caused by poor blood flow to the legs, such as a muscle or bone injury
- Gangrene or ulcers (sores) on the toes or feet
- Being pregnant or breastfeeding now
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- be able to provide written informed consent
- be 19 years of age or older
- having or not having a diagnosis of peripheral artery disease
Who cannot take part
- having a current or pervious aortic aneurysm with or without previous intervention
- having previous revascularization surgeries (open or endovascular) of the legs or aorta
- having walking impairments independent of lower-limb ischemia (e.g., musculoskeletal injury)
- having gangrene or ulcers of the toes/feet
- being currently pregnant or breastfeeding
Where in United States
- University of Nebraska at Omaha Health Science CollaborativeOmaha, United StatesContact: Cody P Anderson, PhDTaking people
About the trial
What the trial wants to find out
1) The purpose of this study is to assess segmental pulse arrival time (PAT) as an alternative biomarker to detect lower-extremity peripheral artery disease (PAD), and to investigate the impacts of local skin heating and foot elevation. The secondary purpose will be to investigate the impacts of age on segmental PAT. The subject population will include any adults 19 years of age or older with or without PAD. Exclusion criteria include having an aortic aneurysm with or without previous intervention, previous revascularization surgeries of the arteries in the legs/aorta, walking impairments independent of PAD, gangrene or ulcers of the toes/feet, and currently pregnant or breastfeeding. 3) All aims of the present study will be completed with a single laboratory visit. Descriptive measurements will include height, weight, age, sex, body fat percentage, and self-reported medication and health history. Subjects will lie in the supine position for 20-min. After rest, either the ankle-brachial index (ABI) or PAT will be assessed. After 10-min of further rest, the other measurement will be performed. ABIs will be assessed according to current guidelines: blood pressures will be assessed in the dorsal pedis and tibialis posterior arteries of both legs and the brachial arteries of both arms using a blood pressure cuff and Doppler ultrasound. PAT will be simultaneously assessed in both arms and legs using an investigational device with a 3-lead electrocardiogram sensor and four photoplethysmography (PPG) sensors. A PPG sensor will be applied to a finger on each hand and both big toes. Signals will be collected for 15-min with finger and toe sensor temperatures at 30 C. Toe sensor temperature will then be elevated to 45 C for 15-min. Finally, toe sensor temperature will remain at 45 C, and the feet will be elevated 8-in with a soft cushion for 15-min. Blood pressure in the arm and legs will be assessed at the end of each stage. Thermal images of the fingers and toes will be assessed before using the investigational device and after each stage. Subjects will then participate in a 6-min walking test (6MWT) to objectively establish walking capacity. The 6MWT will be performed in accordance with current guidelines. Segmental PATs will be compared with ABI and 6-min walking time to determine if segmental PATs can predict lower-extremity PAD (ABI) and the associated walking impairment (6MWT). This study is expected to last ~2.5hrs. 4) There will be no follow-up.
The group in the trial
- Laboratory Visit #1Treatment being tested
During the first and only laboratory visit, subjects will be tested 1) with the experimental device, 2) an ankle-brachial index will be performed, and 3) a 6-min walking test will be performed.
Treatment: Segmental pulse arrival time assessment
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Pulse Arrival Time as an Alternative Biomarker to Detect Lower-Extremity Peripheral Artery Disease
- Plain-language title
- Using the pulse to detect peripheral artery disease in the legsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 17 September 2026